Picture Berlin Partner Join Cluster HealthCapital Berlin Brandenburg 650x100px
Financing › Details

Chr. Hansen–Novozymes: investment, 202212– merger acquisition valuing Chr Hansen at DKK660.55/share ANNOUNCED


Period Period 2022-12-12
Organisations Money taker Chr. Hansen Holding A/S
  Group Chr. Hansen (Group)
  Money source Novozymes A/S
  Group Novozymes (Group)
Products Product industrial biotechnology
  Product 2 food ingredient
Person Person Kutay, Kasim (Novo Group 201706 CEO of Novo Holdings A/S)
Document Source Novozymes A/S. (12/12/22). "Press Release: Novozymes and Chr. Hansen to Combine and Create a Leading Global Biosolutions Partner [Not for US, CA, et al.]". Copenhagen.

Record changed: 2022-12-12


Picture EBD Group Bio-Europe Spring 2023 Basel 560x80px

More documents for Chr. Hansen (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Berlin Partner Bionnale 2023 the Life Sciences Event 650x300px

» top